106 related articles for article (PubMed ID: 21237477)
1. Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs).
Kaulitz D; Fiebig U; Eschricht M; Wurzbacher C; Kurth R; Denner J
Virology; 2011 Mar; 411(1):78-86. PubMed ID: 21237477
[TBL] [Abstract][Full Text] [Related]
2. Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs).
Denner J; Mihica D; Kaulitz D; Schmidt CM
Virol J; 2012 Nov; 9():260. PubMed ID: 23126255
[TBL] [Abstract][Full Text] [Related]
3. Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV).
Waechter A; Denner J
Immunol Res; 2014 Jan; 58(1):9-19. PubMed ID: 23729215
[TBL] [Abstract][Full Text] [Related]
4. Mapping of a neutralizing epitope in the surface envelope protein of porcine endogenous retrovirus subgroup B.
Nakaya Y; Hoshino S; Yasuda J; Miyazawa T
J Gen Virol; 2011 Apr; 92(Pt 4):940-4. PubMed ID: 21228129
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of porcine endogenous retrovirus by antibodies against the membrane-proximal external region of the transmembrane envelope protein.
Waechter A; Eschricht M; Denner J
J Gen Virol; 2013 Mar; 94(Pt 3):643-651. PubMed ID: 23223617
[TBL] [Abstract][Full Text] [Related]
6. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation?
Fiebig U; Stephan O; Kurth R; Denner J
Virology; 2003 Mar; 307(2):406-13. PubMed ID: 12667808
[TBL] [Abstract][Full Text] [Related]
8. Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV).
Langhammer S; Fiebig U; Kurth R; Denner J
Vaccine; 2005 May; 23(25):3341-8. PubMed ID: 15837241
[TBL] [Abstract][Full Text] [Related]
9. Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites.
Chiang CY; Pan YR; Chou LF; Fang CY; Wang SR; Yang CY; Chang HY
Virology; 2007 May; 361(2):364-71. PubMed ID: 17222436
[TBL] [Abstract][Full Text] [Related]
10. Increased neutralizing antibody response after simultaneous immunization with leucogen and the feline leukemia virus transmembrane protein.
Langhammer S; Fiebig U; Kurth R; Denner J
Intervirology; 2011 Feb; 54(2):78-86. PubMed ID: 20829603
[TBL] [Abstract][Full Text] [Related]
11. Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope.
Fiebig U; Schmolke M; Eschricht M; Kurth R; Denner J
AIDS; 2009 May; 23(8):887-95. PubMed ID: 19414989
[TBL] [Abstract][Full Text] [Related]
12. Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.
Mühle M; Hoffmann K; Löchelt M; Denner J
Immunol Res; 2013 May; 56(1):61-72. PubMed ID: 23440699
[TBL] [Abstract][Full Text] [Related]
13. Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope.
Li J; Chen X; Jiang S; Chen YH
Biochem Biophys Res Commun; 2008 Nov; 376(1):60-4. PubMed ID: 18762167
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterisation of replicating foamy viral vectors expressing HIV-1 epitopes recognised by broadly neutralising antibodies.
Mühle M; Hoffmann K; Löchelt M; Denner J
Antiviral Res; 2013 Nov; 100(2):314-20. PubMed ID: 24055836
[TBL] [Abstract][Full Text] [Related]
15. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation.
Tacke SJ; Bodusch K; Berg A; Denner J
Xenotransplantation; 2001 May; 8(2):125-35. PubMed ID: 11328583
[TBL] [Abstract][Full Text] [Related]
16. Establishing the reactivity of monoclonal antibodies against porcine endogenous retrovirus envelope protein.
Wang SR; Chang JT; Lin MS; Chiang CY; Chang HY
Intervirology; 2004; 47(2):93-101. PubMed ID: 15192273
[TBL] [Abstract][Full Text] [Related]
17. Tolerance and immune response to the porcine endogenous retrovirus in German landrace pigs immunised with viral proteins.
Denner J; Petersen B; Niemann H
Virus Res; 2015 Oct; 208():39-43. PubMed ID: 26043980
[TBL] [Abstract][Full Text] [Related]
18. Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.
Denner J
Hum Vaccin Immunother; 2013 Mar; 9(3):462-70. PubMed ID: 23249763
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a monoclonal antibody specific to the Gag protein of porcine endogenous retrovirus and its application in detecting the virus infection.
Chiang CY; Chang JT; Lin MS; Wang SR; Chang HY
Virus Res; 2005 Mar; 108(1-2):139-48. PubMed ID: 15681064
[TBL] [Abstract][Full Text] [Related]
20. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation?
Tacke SJ; Kurth R; Denner J
Virology; 2000 Mar; 268(1):87-93. PubMed ID: 10683330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
